Study of CAR T-cell Therapy in Acute Myeloid Leukemia and Multiple Myeloma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Acute Myeloid Leukemia
Related studies linked through entity extraction aliases.
Efprezimod Alfa (CD24Fc, MK-7110) for the Prevention of Acute Graft Versus Host Disease (GVHD) Following Myeloablative Hematopoietic Stem Cell Transplantation (HSCT) (MK-7110-005)
- Status
- TERMINATED
- Phase
- PHASE3
A Study for Participants Who Participated in Prior Clinical Studies of ASTX727 (Standard Dose)
- Status
- ENROLLING_BY_INVITATION
- Phase
- PHASE2
Gemtuzumab Ozogamicin in Induction and Glasdegib in Postremission Therapy in Patients With AML (Acute Myeloid Leukemia)
- Status
- TERMINATED
- Phase
- PHASE3
Study of Enasidenib and Venetoclax in IDH2-Mutated Blood Cancers
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Study of DAC Combined With HAAG Regimen in Newly Diagnosed Younger AML Patients
- Status
- UNKNOWN
- Phase
- PHASE3
IMGN632 as Monotherapy or With Venetoclax and/or Azacitidine for Participants With CD123-Positive Acute Myeloid Leukemia
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Study of DAC Combined With HAAG Regimen in Newly Diagnosed AML Patients Older Than 60
- Status
- UNKNOWN
- Phase
- PHASE3
Cord Blood Transplant With Dilanubicel for the Treatment of HIV Positive Hematologic Cancers
- Status
- TERMINATED
- Phase
- PHASE2
LY3214996 in Patients With AML Who Are Not Candidates for Standard Therapy
- Status
- COMPLETED
- Phase
- PHASE1
A Phase 1b Master Trial to Investigate CPX-351 in Subjects With Previously Untreated Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- PHASE1
Italian Observational Study of Patients With Acute Myeloid Leukemia Treated With Small Molecule Inhibiting BCL-2
- Status
- UNKNOWN
- Phase
- N/A
Study of the Safety and Efficacy of Gemtuzumab Ozogamicin (GO) and Venetoclax in Patients With Relapsed or Refractory CD33+ Acute Myeloid Leukemia:Big Ten Cancer Research Consortium BTCRC-AML17-113
- Status
- COMPLETED
- Phase
- PHASE1
IA14 Induction in Young Acute Myeloid Leukemia
- Status
- UNKNOWN
- Phase
- PHASE2
Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
First in Human Study of Ziftomenib in Relapsed or Refractory Acute Myeloid Leukemia
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Randomized Clinical Study Assessing Haplo vs. URD in AML
- Status
- TERMINATED
- Phase
- NA
A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
AZA + Venetoclax as Maintenance Therapy in Patients With AML in Remission
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Screening Gene Mutations in Myeloid Cancers by Next Generation Sequencing to Improve Treatment Results
- Status
- UNKNOWN
- Phase
- N/A